Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Maintenance of genome stability by Fanconi anemia proteins.

Palovcak A, Liu W, Yuan F, Zhang Y.

Cell Biosci. 2017 Feb 22;7:8. doi: 10.1186/s13578-016-0134-2. eCollection 2017. Review.

2.

Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.

Mamrak NE, Shimamura A, Howlett NG.

Blood Rev. 2016 Oct 13. pii: S0268-960X(16)30054-6. doi: 10.1016/j.blre.2016.10.002. [Epub ahead of print] Review.

PMID:
27760710
3.

Update of the human and mouse Fanconi anemia genes.

Dong H, Nebert DW, Bruford EA, Thompson DC, Joenje H, Vasiliou V.

Hum Genomics. 2015 Nov 24;9:32. doi: 10.1186/s40246-015-0054-y. Review.

4.

A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.

Solomon PJ, Margaret P, Rajendran R, Ramalingam R, Menezes GA, Shirley AS, Lee SJ, Seong MW, Park SS, Seol D, Seo SH.

Ital J Pediatr. 2015 May 8;41:38. doi: 10.1186/s13052-015-0142-6. Review.

5.

Coregulation of FANCA and BRCA1 in human cells.

Haitjema A, Mol BM, Kooi IE, Massink MP, Jørgensen JA, Rockx DA, Rooimans MA, de Winter JP, Meijers-Heijboer H, Joenje H, Dorsman JC.

Springerplus. 2014 Jul 28;3:381. doi: 10.1186/2193-1801-3-381. eCollection 2014.

6.

PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.

Park JY, Zhang F, Andreassen PR.

Biochim Biophys Acta. 2014 Aug;1846(1):263-75. doi: 10.1016/j.bbcan.2014.06.003. Epub 2014 Jul 3. Review.

7.

Human Fanconi anemia complementation group a protein stimulates the 5' flap endonuclease activity of FEN1.

Qian L, Yuan F, Rodriguez-Tello P, Padgaonkar S, Zhang Y.

PLoS One. 2013 Dec 4;8(12):e82666. doi: 10.1371/journal.pone.0082666. eCollection 2013.

8.

TNF-α signaling in Fanconi anemia.

Du W, Erden O, Pang Q.

Blood Cells Mol Dis. 2014 Jan;52(1):2-11. doi: 10.1016/j.bcmd.2013.06.005. Epub 2013 Jul 24. Review.

9.

A protein prioritization approach tailored for the FA/BRCA pathway.

Haitjema A, Brandt BW, Ameziane N, May P, Heringa J, de Winter JP, Joenje H, Dorsman JC.

PLoS One. 2013 Apr 19;8(4):e62017. doi: 10.1371/journal.pone.0062017. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/bd2ee3f6-0f2b-4814-9825-7b90a40fb91f.

10.

The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.

Romick-Rosendale LE, Lui VW, Grandis JR, Wells SI.

Mutat Res. 2013 Mar-Apr;743-744:78-88. doi: 10.1016/j.mrfmmm.2013.01.001. Epub 2013 Jan 17. Review.

11.

FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.

Panneerselvam J, Park HK, Zhang J, Dudimah FD, Zhang P, Wang H, Fei P.

Cell Cycle. 2012 Aug 1;11(15):2947-55. doi: 10.4161/cc.21400. Epub 2012 Aug 1.

12.

Towards a molecular understanding of the fanconi anemia core complex.

Hodson C, Walden H.

Anemia. 2012;2012:926787. doi: 10.1155/2012/926787. Epub 2012 May 22.

13.

FANCP/SLX4: a Swiss army knife of DNA interstrand crosslink repair.

Cybulski KE, Howlett NG.

Cell Cycle. 2011 Jun 1;10(11):1757-63. Epub 2011 Jun 1. Review.

14.

Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Castella M, Pujol R, Callén E, Trujillo JP, Casado JA, Gille H, Lach FP, Auerbach AD, Schindler D, Benítez J, Porto B, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Torrent M, Estella J, Dasí A, Rodríguez-Villa A, Gómez P, Barbot J, Tapia M, Molinés A, Figuera A, Bueren JA, Surrallés J.

Blood. 2011 Apr 7;117(14):3759-69. doi: 10.1182/blood-2010-08-299917. Epub 2011 Jan 27.

15.

The structure of the catalytic subunit FANCL of the Fanconi anemia core complex.

Cole AR, Lewis LP, Walden H.

Nat Struct Mol Biol. 2010 Mar;17(3):294-8. doi: 10.1038/nsmb.1759. Epub 2010 Feb 14.

16.

Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.

Yarde DN, Oliveira V, Mathews L, Wang X, Villagra A, Boulware D, Shain KH, Hazlehurst LA, Alsina M, Chen DT, Beg AA, Dalton WS.

Cancer Res. 2009 Dec 15;69(24):9367-75. doi: 10.1158/0008-5472.CAN-09-2616.

17.

How the fanconi anemia pathway guards the genome.

Moldovan GL, D'Andrea AD.

Annu Rev Genet. 2009;43:223-49. doi: 10.1146/annurev-genet-102108-134222. Review.

18.

Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.

Singh TR, Bakker ST, Agarwal S, Jansen M, Grassman E, Godthelp BC, Ali AM, Du CH, Rooimans MA, Fan Q, Wahengbam K, Steltenpool J, Andreassen PR, Williams DA, Joenje H, de Winter JP, Meetei AR.

Blood. 2009 Jul 2;114(1):174-80. doi: 10.1182/blood-2009-02-207811. Epub 2009 May 7.

19.

The fanconi anemia core complex acts as a transcriptional co-regulator in hairy enhancer of split 1 signaling.

Tremblay CS, Huard CC, Huang FF, Habi O, Bourdages V, Lévesque G, Carreau M.

J Biol Chem. 2009 May 15;284(20):13384-95. doi: 10.1074/jbc.M807921200. Epub 2009 Mar 25.

20.

Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.

Andreassen PR, Ren K.

Curr Cancer Drug Targets. 2009 Feb;9(1):101-17. Review.

Supplemental Content

Support Center